NASDAQ:ATRI - Atrion Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Atrion Co. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $683.78 +27.08 (+4.12 %) (As of 02/18/2020 02:36 AM ET) Add Compare Today's Range$647.00Now: $683.78▼$683.7850-Day Range$656.70MA: $712.45▼$754.8852-Week Range$647.00Now: $683.78▼$948.03Volume5,163 shsAverage Volume5,574 shsMarket Capitalization$1.26 billionP/E Ratio34.94Dividend Yield0.91%Beta0.15 ProfileAdvanced ChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Atrion Corporation develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications worldwide. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. Read More… Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical & medical instruments Sub-IndustryHealth Care Supplies SectorMedical Current SymbolNASDAQ:ATRI Previous Symbol CUSIP04990410 CIK701288 Webhttp://www.atrioncorp.com/ Phone972-390-9800Debt Debt-to-Equity RatioN/A Current Ratio12.72 Quick Ratio9.35Price-To-Earnings Trailing P/E Ratio34.94 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$152.45 million Price / Sales8.30 Cash Flow$23.41 per share Price / Cash Flow29.21 Book Value$113.76 per share Price / Book6.01Profitability EPS (Most Recent Fiscal Year)N/A Net Income$34.26 million Net Margins23.43% Return on Equity16.45% Return on Assets14.91%Miscellaneous Employees570 Outstanding Shares1,850,000Market Cap$1.26 billion Next Earnings Date2/25/2020 (Estimated) OptionableNot Optionable Receive ATRI News and Ratings via Email Sign-up to receive the latest news and ratings for ATRI and its competitors with MarketBeat's FREE daily newsletter. NASDAQ:ATRI Rates by TradingView Atrion (NASDAQ:ATRI) Frequently Asked Questions What is Atrion's stock symbol? Atrion trades on the NASDAQ under the ticker symbol "ATRI." How often does Atrion pay dividends? What is the dividend yield for Atrion? Atrion declared a quarterly dividend on Tuesday, November 12th. Stockholders of record on Monday, December 2nd will be paid a dividend of $1.55 per share on Monday, December 16th. This represents a $6.20 annualized dividend and a dividend yield of 0.91%. The ex-dividend date is Friday, November 29th. View Atrion's Dividend History. How were Atrion's earnings last quarter? Atrion Co. (NASDAQ:ATRI) posted its earnings results on Friday, November, 1st. The medical instruments supplier reported $5.15 earnings per share (EPS) for the quarter. The medical instruments supplier earned $38.88 million during the quarter. Atrion had a return on equity of 16.45% and a net margin of 23.43%. View Atrion's Earnings History. When is Atrion's next earnings date? Atrion is scheduled to release their next quarterly earnings announcement on Tuesday, February 25th 2020. View Earnings Estimates for Atrion. Has Atrion been receiving favorable news coverage? News headlines about ATRI stock have been trending very negative this week, InfoTrie Sentiment reports. The research group rates the sentiment of news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Atrion earned a news sentiment score of -3.4 on InfoTrie's scale. They also gave media headlines about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for Atrion. Who are some of Atrion's key competitors? Some companies that are related to Atrion include Align Technology (ALGN), Cooper Companies (COO), West Pharmaceutical Services (WST), DENTSPLY SIRONA (XRAY), Haemonetics (HAE), ICU Medical (ICUI), Neogen (NEOG), Quidel (QDEL), Merit Medical Systems (MMSI), STAAR Surgical (STAA), Cerus (CERS), Anika Therapeutics (ANIK), Antares Pharma (ATRS), OraSure Technologies (OSUR) and Utah Medical Products (UTMD). What other stocks do shareholders of Atrion own? Based on aggregate information from My MarketBeat watchlists, some companies that other Atrion investors own include ABM Industries (ABM), International Paper (IP), AT&T (T), Westrock (WRK), Exxon Mobil (XOM), Gilead Sciences (GILD), Methanex (MEOH), Pattern Energy Group (PEGI), Walgreens Boots Alliance (WBA) and AbbVie (ABBV). Who are Atrion's key executives? Atrion's management team includes the folowing people: Mr. Emile A. Battat, Exec. Chairman (Age 81)Mr. David A. Battat, Pres & CEO (Age 49)Mr. Jeffery Strickland, VP, CFO, Treasurer & Sec. (Age 60) Who are Atrion's major shareholders? Atrion's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Kayne Anderson Rudnick Investment Management LLC (9.95%), Renaissance Technologies LLC (2.67%), State Street Corp (2.52%), Royce & Associates LP (1.93%), Boston Trust Walden Corp (1.01%) and ProShare Advisors LLC (0.97%). Company insiders that own Atrion stock include Emile A Battat, Jeffery Strickland, John P Stupp Jr and Ronald Nicholas Spaulding. View Institutional Ownership Trends for Atrion. Which major investors are selling Atrion stock? ATRI stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Kayne Anderson Rudnick Investment Management LLC, SG Americas Securities LLC, Public Sector Pension Investment Board, AQR Capital Management LLC, Morgan Dempsey Capital Management LLC, Denali Advisors LLC and California Public Employees Retirement System. Company insiders that have sold Atrion company stock in the last year include John P Stupp Jr and Ronald Nicholas Spaulding. View Insider Buying and Selling for Atrion. Which major investors are buying Atrion stock? ATRI stock was acquired by a variety of institutional investors in the last quarter, including Boston Trust Walden Corp, Marshall Wace LLP, ProShare Advisors LLC, Aviva PLC, ICW Investment Advisors LLC, Goldman Sachs Group Inc., Bank of Montreal Can and PBMares Wealth Management LLC. View Insider Buying and Selling for Atrion. How do I buy shares of Atrion? Shares of ATRI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is Atrion's stock price today? One share of ATRI stock can currently be purchased for approximately $683.78. How big of a company is Atrion? Atrion has a market capitalization of $1.26 billion and generates $152.45 million in revenue each year. Atrion employs 570 workers across the globe.View Additional Information About Atrion. What is Atrion's official website? The official website for Atrion is http://www.atrioncorp.com/. How can I contact Atrion? Atrion's mailing address is ONE ALLENTOWN PARKWAY, ALLEN TX, 75002. The medical instruments supplier can be reached via phone at 972-390-9800 or via email at [email protected] MarketBeat Community Rating for Atrion (NASDAQ ATRI)Community Ranking: 2.3 out of 5 ( )Outperform Votes: 122 (Vote Outperform)Underperform Votes: 144 (Vote Underperform)Total Votes: 266MarketBeat's community ratings are surveys of what our community members think about Atrion and other stocks. Vote "Outperform" if you believe ATRI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ATRI will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/18/2020 by MarketBeat.com StaffFeatured Article: What is meant by buying and selling pressure?
